The ENDURACELL brand, founded in 1970 (Belgium), from 218 sister brands and 4958 competing brands. The ENDURACELL brand is owned by Zoetis, a company listed in New York. ENDURACELL is part of the Drug Manufacturers activity sector.
Share price and profitability of the share Zoetis (ENDURACELL)
Buy Zoetis share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Zoetis
(ENDURACELL)
over 5 years*
USD 244.80
Stock market history Zoetis (ENDURACELL)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
